Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epidemiological 2-year Prospective Study to Estimate the Prevalence and Evolution of Heart Failure and Identify Potential Predictors for the Development of Symptomatic HF in Patients withT2 Diabetes Mellitus at High CV Risk

NCT04482283 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04482283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04482283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epidemiological 2-year Prospective Study to Estimate the Prevalence and Evolution of Heart Failure and Identify Potential Predictors for the Development of Symptomatic HF in Patients withT2 Diabetes Mellitus at High CV Risk
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
July 20, 2020
Completion date
November 21, 2024
Enrollment
245 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

related registry search